Half Year 2025 Ucb SA Earnings Call Transcript
Good afternoon, good morning, good evening.
Welcome to the UCB half-year 2025 Capital Market Call. My name is Antje, I'm the Head of Investor Relations at UCB.
Before I introduce you to the agenda and hand over to the speakers today, I'd like to make some remarks. This presentation and the following Q&A session are intended for institutional capital market participants. If you're not, please disconnect now.
This video conference is being recorded. You can find the presentation in our Download Center on our website in the Investor Relations section, of course, if you dial in by phone. And this presentation and the following Q&A session are covered by the disclaimer and Safe Harbor statement as stated on the slide 2 of the slide deck. Please kindly read and respect this carefully.
With this, I'd like to introduce you to our speakers today: our CEO, Jean-Christophe Tellier; Fiona du Monceau, Head of Patient Evidence; Emmanuel Caeymaex, Chief Commercial Officer; and of course, CFO, Sandrine Dufour. And then we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
